false
Catalog
The Science and Practice of Treating Patients with ...
3 easy_buprenorphine_prescribing_for_everyone_-_sa ...
3 easy_buprenorphine_prescribing_for_everyone_-_sarah_spencer,_do,_fasam (1080p)
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The transcript covers the use of buprenorphine for treating opioid use disorder, stressing its importance over detox alone to reduce mortality rates. It details the pharmacology, common side effects, and strategies for initiating treatment without causing withdrawal. The discussion also addresses misconceptions around buprenorphine and challenges posed by fentanyl use. Emphasis is placed on understanding patients' social situations, optimizing dosages, and being well-informed to effectively manage opioid use disorder and reduce mortality rates. Additionally, the complexities of administering and tapering buprenorphine, particularly in fentanyl withdrawal cases, are discussed. Long-acting injectable buprenorphine is highlighted as a convenient option, and the importance of patient-centered decisions and trust in patient self-reporting is emphasized. The transcript offers resources for further reading and guidance on managing buprenorphine treatment scenarios, emphasizing individualized care and patient involvement in decision-making.
Keywords
buprenorphine
opioid use disorder
detox
mortality rates
pharmacology
side effects
treatment initiation
withdrawal
fentanyl
patient-centered care
long-acting injectable
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.
Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
8-Hour DEA Training Inquiries, email
PCSS-MOUD
.
ORN
opioidresponsenetwork.org
×
Please select your language
1
English